Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Return on Sales (2016 - 2025)

Historic Return on Sales for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to 0.01%.

  • Integra Lifesciences Holdings' Return on Sales rose 100.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year decrease of 3000.0%. This contributed to the annual value of 0.0% for FY2024, which is 500.0% down from last year.
  • Latest data reveals that Integra Lifesciences Holdings reported Return on Sales of 0.01% as of Q3 2025, which was up 100.0% from 1.16% recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Return on Sales registered a high of 0.13% during Q4 2022, and its lowest value of 1.16% during Q2 2025.
  • For the 5-year period, Integra Lifesciences Holdings' Return on Sales averaged around 0.01%, with its median value being 0.05% (2023).
  • Per our database at Business Quant, Integra Lifesciences Holdings' Return on Sales skyrocketed by 1000bps in 2021 and then plummeted by -11400bps in 2025.
  • Quarter analysis of 5 years shows Integra Lifesciences Holdings' Return on Sales stood at 0.11% in 2021, then increased by 19bps to 0.13% in 2022, then tumbled by -62bps to 0.05% in 2023, then dropped by -12bps to 0.04% in 2024, then tumbled by -131bps to 0.01% in 2025.
  • Its Return on Sales stands at 0.01% for Q3 2025, versus 1.16% for Q2 2025 and 0.07% for Q1 2025.